1 / 9

Increase In Clinical Trials For Pigment Glaucoma In Global Market Outlook: Ken Research

The treatment of pigment glaucoma includes minoring pressure using surgery, laser or medications. Unfortunately, it is very difficult to lessen or eliminate the release of iris pigment. Hence, more observation is focused on reducing eye pressure.

kenresearch23
Download Presentation

Increase In Clinical Trials For Pigment Glaucoma In Global Market Outlook: Ken Research

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Increase In Clinical Trials For Pigment Glaucoma In Global Market Outlook: Ken Research

  2. Summary • Global Data's clinical trial report, Pigment Glaucoma Global Clinical Trials Review, H1, 2018 provides an overview of Pigment Glaucoma clinical trials scenario. This report provides top line data relating to the clinical trials on Pigment Glaucoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe.

  3. - According to the report analysis, ‘Pigment Glaucoma Global Clinical Trials Review, H1, 2018’ suggests that some of the major companies and health organizations are functioning in this for doing the efficient treatment of the pigment glaucoma such as novartis, agallergan, plc clinuvel pharmaceuticals ltd, valeant pharmaceuticals international inc, pharmaceutical co ltd. • Anderson cancer center, wyeth pharmaceuticals inc., gehealtcare, Columbia university, vanderbilt medical center, bristol-myers squib company, copharos inc., national cancer center, bayerag, mayo clinic, duke university, university of pennsylvania, duke university and others. Moreover, the organizations are working very efficiently for solving the problem of pigment with the more experiments and the development in the instruments.

  4. PigmentaryGlaucoma is a type of assumed open-angle glaucoma which develops more frequently in men than in women. Pigment glaucoma is the discharge of pigment from the posterior aspect of the iris into the anterior segment following the flow of melting humor. Pigment glaucoma is commonly presents between the second and forth decades, which is earlier than other types of glaucoma. • Pigment glaucoma can result to significant damage to the drain and elevate eye pressure. By the time, the elevated eye pressure can damage the optic nerve and causing pigmentary glaucoma. Whereas, the untreated glaucoma can result to loss of vision and become worsen such as lead to complete blindness. Geographically, the Asia-pacific region, Europe, north America, middle east and Africa, central and South America shows the frequentness in the treatment of the pigment glaucoma.

  5. The treatment of pigment glaucoma includes minoring pressure using surgery, laser or medications. Unfortunately, it is very difficult to lessen or eliminate the release of iris pigment. • Hence, more observation is focused on reducing eye pressure. Not only has this, patients of pigmentary glaucoma can be treated successfully and thankfully, with the development in the modern treatments, many victims are able to maintain excellent vision. With the dangerous cause of vision loss many key players are working very effectively, they started making eye drops for resolving the problem and doing great job in the treatment with enhanced technologies. Therefore, the future of these clinical trials is expected to be bright in the coming years.

  6. Browse Full Market Report • Pigment Glaucoma Global Clinical Trials Review, H1, 2018 • Related reports: • Open-Angle Glaucoma Global Clinical Trials Review, H1, 2018 • EpiCast Report: Glaucoma-Epidemiology Forecast to 2026

  7. About Ken Research • Ken Research provides bespoke industry intelligence, equity research reports and business consulting services on gamut of sectors across the globe. We use advanced information management tools, sophisticated analytical systems and methodologies to help our clients with crucial industry information for decision making. • As a leading Online Market Research Report Seller, Ken Research act as a platform for accessing statistics, forecast, business insights, Ideas, concepts and much more.

  8. Contact Us: Ken Research Ankur Gupta, Head Marketing & Communications • sales@kenresearch.com • +91-9015378249

More Related